Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Inappropriate Use Of Amfepramone Prompts EU Withdrawal Of Weight-Loss Drug
EMA Issues Warning Over Xalkori And Oular Toxicity In Pediatric Patients
Jun 13 2022
•
By
Vibha Sharma
Amfepramone medicines were being used for longer than the recommended maximum three-month period • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Europe
More from Geography